Medical Hyperspectral Imaging Market to have robust growth during 2022-2028

The medical hyperspectral imaging market refers to the use of hyperspectral imaging technology in the medical field for diagnostic and therapeutic applications. Hyperspectral imaging is an imaging technique that combines the power of spectroscopy and imaging to capture both spatial and spectral information from a scene. In the medical field, hyperspectral imaging can be used to identify and classify tissues, monitor tissue oxygenation, and detect diseases such as cancer.

The global medical hyperspectral imaging market is expected to grow at a significant rate in the coming years, driven by factors such as the increasing demand for non-invasive diagnostic tools, the rising prevalence of chronic diseases such as cancer, and the growing adoption of hyperspectral imaging technology by healthcare providers. The medical hyperspectral imaging market was estimated at US$ 304.06 billion in 2021 and is expected to grow at a CAGR of 3.71% during 2022-2028 to reach US$ ~372.20 billion in 2028.

Request a sample here:

https://www.stratviewresearch.com/Request-Sample/3166/medical-hyperspectral-imaging-market.html#form

The following are the major players in the medical hyperspectral imaging market:

• IMEC
• Norsk Elektro Optikk
• Galileo
• Gilden Photonics
• Resonon
• XIMEA
• Gooch & Housego
• Chemlmage
• Applied Spectral Imaging
• Cubert
• EVK DI Kerschhaggl
• Headwall Photonics
• FluxData

The medical hyperspectral imaging market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America dominates the medical hyperspectral imaging market. This could be due to the fact that hyperspectral imaging was originally extensively used in the United States. Furthermore, investment in the healthcare industry is moving the North American market ahead. After North America, Europe is the world's second-largest market for medical hyperspectral imaging. At the moment, Europe controls a sizable portion of the worldwide market. This region's size can be attributed to the presence of well-developed research infrastructure, the availability of technologically advanced imaging products, and the rising adoption of hyperspectral imaging in battlefield surveillance, environmental control, mining, machine vision, as well as life sciences and diagnostics.

Overall, the medical hyperspectral imaging market is expected to continue to grow as healthcare providers seek to improve patient outcomes through the use of advanced diagnostic and therapeutic tools.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis.
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics: Market share, Product portfolio, New Product Launches, etc.
• Attractive market segments and associated growth opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing and new players.
• Key success factors.

 

 

Metabolomics Market Study Offering Insights on Latest Advancements, Trends & Analysis from 2022 to 2028

This new report from Stratview Research analyses the Metabolomics Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

Metabolomics Market Overview:

The metabolomics market was estimated at US$ 2.3 billion in 2021 and is expected to grow at a CAGR of 14.86% during 2022-2028 to reach US$ 6.18 billion in 2028.

Drivers

The following are the major players in the metabolomics market:

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Danaher Corporation
• Human Metabolome Technologies Inc.
• Metabolon, Inc.
• Shimadzu Corporation
• Waters Corporation

Segment Analysis

The market is divided based on product and service, technology, application, and end user. On the basis of product and service, the market is further segmented into metabolomics instruments, and metabolomics bioinformatics tools and services. The instruments segment is further divided into seperation tools and detection tools. The separation tools is segmented into high-performance liquid chromatography (HPLC), gas chromatography (GC), ultra-performance liquid chromatography (UPLC), capillary electrophoresis (CE). The detection tools is segmented into mass spectrometry, nuclear magnetic resonance spectroscopy (NMR), surface-based mass analysis.

Based on clinical indication, the metabolomics market has been divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. The metabolomics market is mostly driven by cancer among the various clinical indications. The increased frequency of cancer worldwide and the expansion of oncological research efforts are the main causes of this. The World Health Organization (WHO) reports that cancer was the second biggest cause of death worldwide, accounting for 8.8 million fatalities. Cardiovascular problems, neurological conditions, inborn metabolic abnormalities, and other clinical indications for metabolomics are also included.

The metabolomics market is broken down geographically into geographies, namely North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Due to factors including the presence of several financing sources from both public and private agencies, the accessibility of technologically cutting-edge products, and the dominance of some of the important firms in the region, North America is the largest market for metabolomics goods and services. The metabolomics market is anticipated to develop at the quickest rate during the forecast period in Asia-Pacific. Its expansion is primarily being driven by rising healthcare and R&D spending, an increase in the use of technology in clinical settings, and a growing interest among large businesses in exploring unexplored markets.

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/3168/metabolomics-market.html#form

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: [e-mail]
Direct: [phone]

 

Organ on Chip Market: Global Outlook, Key Developments, And Market Share Analysis | 2022-28

Organ on Chip Market  report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

The  organ on chip market  was estimated at  US$ 111 million in 2021  and is expected to grow at a  CAGR of 28.43%  during 2022-2028 to reach  US$ 647.6 million in 2028. Organs-on-chips (OOCs) are miniature plastic gadgets with biocompatible microfluidic chambers that house numerous living human cells in a 3D culture to mimic various physiological functions of body organs. A promising substitute for animal models are organs-on-chips that replicate the physiology of human organs at the cellular level.

Analysis Segment

The market is divided based on offering, organ, application, and end user. On the basis of offering, the market is segmented into devices, testing services.

On the basis of organ, the market is divided into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain -barrier-on-chip, others. Due to fewer lung transplants, which has prompted the development of laboratory-engineered chips to mimic their functions and for drug screening for respiratory disorders, the lung-on-chip segment of the organ-on-chip market has dominated the market since 2021 and is predicted to continue dominating during the forecast period.

On the basis of application, the market is further segmented into toxicology research, drug discovery, molecular biology, disease modeling, food safety and others.

The organ on chip market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2021, North America held the largest share of the worldwide organ-on-chip market, and it is expected to hold this position throughout the forecast period. This is attributable to a growth in the use of technologically advanced models, the presence of important players, and an increase in research and development operations for the development of new drugs. However, because to an increase in R&D efforts, an increase in healthcare spending, and diverse tactics among key competitors, the Asia-Pacific region is predicted to have a significant organ-on-chip market opportunity. In addition, according to the prediction for the Asia-Pacific organ-on-chip market, India and China would expand at rapid CAGRs.

Request a Sample here:

https://www.stratviewresearch.com/Request-Sample/3177/organ-on-chip-market.html#form

Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research's internal database and statistical tools.

The Organ on Chip Market analysis report discusses the following heads in great detail:

• Market structure: Overview, industry life cycle analysis, supply chain analysis
• COVID-19 Impact Assessment
• Market environment analysis: Growth drivers and constraints, Porter's five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for existing and new players
• Key success factors

About Stratview Research

Stratview Research is a trusted brand globally, providing high quality research and strategic insights that help companies worldwide in effective decision making. It is a global market intelligence firm providing a wide range of services including syndicated market reports, custom research, and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

Contact: Stratview Research

Email: [e-mail]

Direct: [phone]